Problems of case and disease management in outpatient treatment of influenza Klaus-Dieter Kossow Review Pages: 129 - 132
Antigenic drift and variability of influenza viruses B. Schweiger I. Zadow R. Heckler Original Investigation Pages: 133 - 138
Real-time influenza surveillance in Germany – Results of a pilot project W. Lange M. Schöttler Original Investigation Pages: 139 - 144
Some aspects regarding the interpretation of influenza surveillance data H. Uphoff J. Cohen Original Investigation Pages: 145 - 149
Acute respiratory diseases/influenza sentinel 2000/2001 S. Bigl I. Briem G. Nowotnik Original Investigation Pages: 151 - 156
Laboratory diagnosis of influenza – virology or serology? R. Allwinn W. Preiser H. Doerr Review Pages: 157 - 160
Neuraminidase inhibitors in the management of influenza – experience of an outpatient practice Georg E. Vogel Clinical Practice Pages: 161 - 163
Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment Adrian GillissenGert Höffken Review Pages: 165 - 168
Efficacy and safety of zanamivir in patients with influenza – impact of age, severity of infections and specific risk factors Gert HöffkenAdrian Gillissen Review Pages: 169 - 173
Cyanobacteria a potential source of antiviral substances against influenza virus E. Zainuddin S. Mundt R. Mentel Original Investigation Pages: 181 - 182
Conceptional considerations for a German influenza pandemic preparedness plan R. Fock H. Bergmann A. Wirtz Viewpoint Pages: 191 - 195
Experience with the clinical development of influenza vaccines for potential pandemics J. Wood K. Nicholson A. Podda Original Investigation Pages: 197 - 201
Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines N. Hehme H. Engelmann R. Sänger Original Investigation Pages: 203 - 208
